Preclinical Metabolism, Pharmacokinetics and In Vivo Analysis of New Blood-Brain-Barrier Penetrant Fingolimod Analogues: FTY720-C2 and FTY720-Mitoxy.
Parkinson's disease (PD) is a neurodegenerative aging disorder in which postmortem PD brain exhibits neuroinflammation, as well as synucleinopathy-associated protein phosphatase 2A (PP2A) enzymatic activity loss. Based on our translational research, we began evaluating the PD-repurposing-potent...
Main Authors: | Julius O Enoru, Barbara Yang, Sesha Krishnamachari, Ernesto Villanueva, William DeMaio, Adiba Watanyar, Ramesh Chinnasamy, Jeffrey B Arterburn, Ruth G Perez |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5017749?pdf=render |
Similar Items
-
FTY720-derivatives do not induce FTY720-like lymphopenia
by: Ismael Segura-Ulate, et al.
Published: (2017-03-01) -
FTY720 in hematopoietic cell transplantation FTY720 no transplante de células hematopoéticas
by: Valquiria Bueno
Published: (2008-01-01) -
FTY720/fingolimod, a sphingosine analogue, reduces amyloid-β production in neurons.
by: Nobumasa Takasugi, et al.
Published: (2013-01-01) -
The Immunosuppressant FTY720 (Fingolimod) enhances Glycosaminoglycan depletion in articular cartilage
by: Stradner Martin H, et al.
Published: (2011-12-01) -
The Immunosuppressant Fingolimod (FTY720) for the Treatment of Mechanical Force-Induced Abnormal Scars
by: Masayo Aoki, et al.
Published: (2020-01-01)